Pulseselect News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pulseselect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pulseselect Today - Breaking & Trending Today
Continuing the spate of regulatory approvals for pulsed field ablation (PFA) devices around the world, Johnson & Johnson’s Biosense Webster Inc. unit secured CE mark for the Varipulse platform for treatment of symptomatic, drug-refractory recurrent paroxysmal atrial fibrillation. ....
The U.S. FDA added a second pulsed field ablation (PFA) system to the approved list with its greenlight for Boston Scientific Corp.’s Farapulse for treatment of atrial fibrillation (AF). Farapulse joins Medtronic plc’s Pulseselect, which garnered FDA approval in December. Two other PFA devices scored regulatory wins since the new year: Biosense Webster inc.’s Varipulse secured approval from the Japanese Ministry of Health Labor and Welfare and Sichaun Jinjiang Electronic Medical Device Technology Co. Ltd. got the nod from China’s National Medical Products Administration. ....
Biosense Webster Inc. scored approval from Japan’s Ministry of Health Labour and Welfare’s (MHLW) for its Varipulse pulsed field ablation platform to treat symptomatic drug-refractory recurrent paroxysmal atrial fibrillation on Jan. 9., making it the first PFA system approved in the country. ....
Medtronic s PulseSelect Pulsed Field Ablation System has become the first to receive FDA approval for the treatment of both paroxysmal and persistent atrial fib ....
By Michael Dabaie Medtronic PLC said the first procedures were performed in the investigational device exemption pivotal trial of the PulseSelect Pulsed Field Ablation System. PulseSelect uses pulsed electric fields to treat atrial fibrillation. The first procedure in the PULSED AF pivotal trial was performed this week at Southcoast Health in Fall River, Mass., with the second procedure also at Southcoast Health. The PULSED AF Trial aims to establish the safety and efficacy of the PulseSelect System. Atrial fibrillation is one of the most common and undertreated heart rhythm disorders, affecting more than 37 million people worldwide. The disease involves an irregular quivering or rapid heart rhythm in the upper chambers of the heart. ....